
Hansoh Pharmaceutical Investor Relations Material
Latest events
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Hansoh Pharmaceutical Group
Access all reports
Hansoh Pharmaceutical Group is a Chinese pharmaceutical company focused on the research, development, manufacturing, and commercialization of innovative and generic drugs. The company’s product portfolio covers therapeutic areas such as oncology, central nervous system (CNS) disorders, anti-infectives, and diabetes. Hansoh Pharmaceutical places a strong emphasis on innovation, investing in R&D to expand its pipeline with both novel and high-quality generic drugs to address unmet medical needs. The company is headquartered in Lianyungang, China, and its shares are listed on the Hong Kong Stock Exchange.
Latest articles
)
Lowe's Companies: Building a One-Stop Shop for Home Improvement
Lowe's Companies began as a single store in 1921 and has steadily expanded its footprint and offerings, now operating 1,750 stores across the U.S.
7 May 2025
)
Greg Abel: Succeeding Warren Buffett at Berkshire Hathaway
After decades working with Warren Buffett and Charlie Munger, Greg Abel was named Buffett’s successor as he steps down in late 2025.
5 May 2025
)
Intuitive Surgical: Enhancing Surgery with Robotic Precision
Intuitive Surgical has revolutionized surgery with robotics, building its dominant position through decades of innovation, validation, and expansion.
2 May 2025
Ticker symbol
3692
Country
🇭🇰 Hong Kong